I
3.51
-0.01 (-0.28%)
| 前收盘价格 | 3.52 |
| 收盘价格 | 3.52 |
| 成交量 | 199,024 |
| 平均成交量 (3个月) | 1,253,304 |
| 市值 | 126,669,584 |
| 价格/销量 (P/S) | 563.62 |
| 股市价格/股市净资产 (P/B) | 17.48 |
| 52周波幅 | |
| 利润日期 | 11 Aug 2025 |
| 稀释每股收益 (EPS TTM) | -1.97 |
| 总债务/股东权益 (D/E MRQ) | 9.76% |
| 流动比率 (MRQ) | 7.48 |
| 营业现金流 (OCF TTM) | -53.59 M |
| 杠杆自由现金流 (LFCF TTM) | -32.40 M |
| 资产报酬率 (ROA TTM) | -57.90% |
| 股东权益报酬率 (ROE TTM) | -102.47% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | Immuneering Corporation | 看涨 | 看涨 |
AIStockmoo 评分
1.8
| 分析师共识 | 5.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 4.0 |
| 平均 | 1.75 |
|
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 24.12% |
| 机构持股比例 | 12.55% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Southport Management, L.L.C. | 31 Mar 2025 | 245,000 |
| Tidemark, Llc | 31 Mar 2025 | 44,400 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 30.00 (Oppenheimer, 754.70%) | 购买 |
| 中 | 15.50 (341.60%) | |
| 低 | 11.00 (HC Wainwright & Co., 213.39%) | 购买 |
| 11.00 (Needham, 213.39%) | 购买 | |
| 平均值 | 18.00 (412.82%) | |
| 总计 | 4 购买 | |
| 平均价格@调整类型 | 7.84 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| HC Wainwright & Co. | 30 Sep 2025 | 11.00 (213.39%) | 购买 | 7.76 |
| Chardan Capital | 26 Sep 2025 | 20.00 (469.80%) | 购买 | 7.76 |
| 14 Aug 2025 | 13.00 (270.37%) | 购买 | 3.04 | |
| Oppenheimer | 25 Sep 2025 | 30.00 (754.70%) | 购买 | 8.00 |
| Needham | 15 Sep 2025 | 11.00 (213.39%) | 购买 | 7.86 |
| 26 Aug 2025 | 8.00 (127.92%) | 购买 | 5.92 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合